Literature DB >> 16839490

The intragastric balloon - smoothing the path to bariatric surgery.

John Melissas1, John Mouzas, Dimetrios Filis, Markos Daskalakis, Erminia Matrella, John A Papadakis, Nikos Sevrisarianos, Demetris Charalambides.   

Abstract

BACKGROUND: Intragastric balloon placement in association with diet for weight reduction is steadily gaining popularity. However, long-term follow-up studies on the effect of this method in maintaining weight loss are lacking. This study evaluated the long-term outcome following balloon removal in morbidly obese patients who had selected this method for weight loss.
METHODS: 140 morbidly obese patients who refused bariatric surgery because of fear of complications and mortality, underwent intragastric balloon placement and were followed over a 6- to 30-month period (mean 18.3 months) after balloon extraction. The 34 males and 106 females, with median age 38 years (range 16-62), median weight 122 kg (range 85-203), median BMI 42.3 kg/m(2) (range 35-61.3) and median excess weight (EW) 59 kg (range 29-132), received a Bioenterics Intragastric Balloon (BIB). Excess weight loss (EWL) > or =25% when the BIB was removed was considered a success. Weight fluctuations and any further interventional therapy requested by the patients after balloon removal were recorded.
RESULTS: 100 patients (71.4%) lost > or =25% of their EW on balloon extraction and were categorized as successes, while 40 patients (28.6%) did not achieve that weight loss and were categorized as failures of the method. During the follow-up period, 44 of the originally successful patients (31.4%) regained weight and were categorized as recurrences, while the remaining 56 patients (40%) maintained their EWL of > or =25% and were considered long-term successes. During follow-up, 45 patients (32.1%) requested and underwent bariatric surgery for their morbid obesity (21 Adjustable Gastric Band, 11 Laparoscopic Sleeve Gastrectomy, 13 Laparoscopic Gastric Bypass). Of these, 13 (32.5%) were from the group of 40 patients categorized as failures on BIB removal, 28 (63.6%) were from the group of 44 patients whose obesity recurred, and 4 (7.1%) were from the 56 patents who although they maintained successful weight loss requested further weight reduction.
CONCLUSIONS: The BIB served as a first step and a smooth introduction to bariatric surgery for morbidly obese patients who initially refused surgical intervention. The incidence of surgical intervention was double in patients who initially experienced the benefits of weight loss and then had obesity recurrence, compared with patients in whom the method failed. Indeed, a significant number of patients were assisted in their efforts to lose and maintain an acceptable weight loss over a 6- to 30-month follow-up period.

Entities:  

Mesh:

Year:  2006        PMID: 16839490     DOI: 10.1381/096089206777822188

Source DB:  PubMed          Journal:  Obes Surg        ISSN: 0960-8923            Impact factor:   4.129


  36 in total

1.  Intragastric balloon followed by diet vs intragastric balloon followed by another balloon: a prospective study on 100 patients.

Authors:  Alfredo Genco; Massimiliano Cipriano; Vincenzo Bacci; Roberta Maselli; Emanuela Paone; Michele Lorenzo; Nicola Basso
Journal:  Obes Surg       Date:  2010-11       Impact factor: 4.129

2.  Single vs repeated treatment with the intragastric balloon: a 5-year weight loss study.

Authors:  Jean-Marc Dumonceau; Erik François; Axel Hittelet; Abdel Ilah Mehdi; Marie Barea; Jacques Deviere
Journal:  Obes Surg       Date:  2010-06       Impact factor: 4.129

3.  Intragastric balloon treatment of obesity: Long-term results and patient satisfaction.

Authors:  Aline El Haddad; Mohammad O Rammal; Assaad Soweid; Ala I Shararra; Fady Daniel; Mahmoud A Rahal; Yasser Shaib
Journal:  Turk J Gastroenterol       Date:  2019-05       Impact factor: 1.852

4.  Morbidly obese are ghrelin and leptin hyporesponders with lesser intragastric balloon treatment efficiency : ghrelin and leptin changes in relation to obesity treatment.

Authors:  Marko Nikolic; Marko Boban; Neven Ljubicic; Vladimir Supanc; Gorana Mirosevic; Borka Pezo Nikolic; Ruzica Krpan; Ljubica Posavec; Vanja Zjacic-Rotkvic; Miroslav Bekavac-Beslin; Petar Gacina
Journal:  Obes Surg       Date:  2011-10       Impact factor: 4.129

5.  Esophageal perforation after gastric balloon extraction.

Authors:  Dan Ruiz; Kelly Vranas; Davida A Robinson; Liberato Salvatore; James W Turner; Talat Addasi
Journal:  Obes Surg       Date:  2008-08-08       Impact factor: 4.129

Review 6.  Evidence-based review of the Bioenterics intragastric balloon for weight loss.

Authors:  Jean-Marc Dumonceau
Journal:  Obes Surg       Date:  2008-06-21       Impact factor: 4.129

7.  Standardization of Bariatric Metabolic Procedures: World Consensus Meeting Statement.

Authors:  Mohit Bhandari; M A L Fobi; Jane N Buchwald
Journal:  Obes Surg       Date:  2019-07       Impact factor: 4.129

8.  The Impact of Gastric Bypass on Telomere Length and Shelterin Complex Gene Expression: 6 Months Prospective Study.

Authors:  Caroline Rossi Welendorf; Carolina Ferreira Nicoletti; Natália Yumi Noronha; Flávia Campos Ferreira; Letícia Santana Wolf; Marcela Augusta de Souza Pinhel; Vitor Caressato Pinhanelli; Cristiana Cortes de Oliveira; Bruno Affonso Parenti de Oliveira; Luzania Dos Santos Martins; Wilson Salgado Junior; Carla Barbosa Nonino
Journal:  Obes Surg       Date:  2021-03-18       Impact factor: 4.129

9.  Tolerance and efficacy of an air-filled balloon in non-morbidly obese patients: results of a prospective multicenter study.

Authors:  François Mion; Rodica Gincul; Sabine Roman; Sylvain Beorchia; Frank Hedelius; Nicolas Claudel; Roger-Michel Bory; Etienne Malvoisin; Frédérique Trepo; Bertrand Napoleon
Journal:  Obes Surg       Date:  2007-06       Impact factor: 4.129

10.  Analysis of safety and efficacy of intragastric balloon in extremely obese patients.

Authors:  Stephan Göttig; Markos Daskalakis; Sylvia Weiner; Rudolf A Weiner
Journal:  Obes Surg       Date:  2009-03-17       Impact factor: 4.129

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.